Lindy Durrant

Joint CEO

An internationally recognised immunologist in the field of tumour therapy, Prof Durrant has worked for 21 years in translational research, developing products for clinical trials including monoclonal antibodies for diagnostic imaging and therapy and cancer vaccines.

She has a personal Chair in Cancer Immunotherapy at the Department of Clinical Oncology at the University of Nottingham and is currently running clinical trials in colorectal cancer and osteosarcoma.

Related

COMPANY SPOTLIGHT

Menarini

Back to top